Assay News and Research

RSS
Gen-Probe's PROGENSA PCA3 assay helps determine necessity of initial biopsy in prostate cancer suspect men

Gen-Probe's PROGENSA PCA3 assay helps determine necessity of initial biopsy in prostate cancer suspect men

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung cancer patients

Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung cancer patients

Immunomedics' blood assay for PAM4-protein can detect pancreatic cancer and predict early relapse

Immunomedics' blood assay for PAM4-protein can detect pancreatic cancer and predict early relapse

ARIAD presents AP26113 investigational ALK inhibitor preclinical study data at AACR annual meeting

ARIAD presents AP26113 investigational ALK inhibitor preclinical study data at AACR annual meeting

Elan's first-quarter total revenue up by 27% to $310.5M

Elan's first-quarter total revenue up by 27% to $310.5M

ForteBio introduces new Octet QK(e) instrumentation system

ForteBio introduces new Octet QK(e) instrumentation system

AMRI extends and expands research collaboration with CHDI Foundation

AMRI extends and expands research collaboration with CHDI Foundation

TYSABRI drives Biogen Idec's first-quarter revenues of $1.1 billion

TYSABRI drives Biogen Idec's first-quarter revenues of $1.1 billion

Affymetrix introduces new service for obtaining allele-specific copy number data from FFPE samples

Affymetrix introduces new service for obtaining allele-specific copy number data from FFPE samples

Artificial human skin with dermis made from fibrin-agarose biomaterial

Artificial human skin with dermis made from fibrin-agarose biomaterial

Gamma-prime fibrinogen test can help better predict people at risk for heart attack

Gamma-prime fibrinogen test can help better predict people at risk for heart attack

S1P5 may serve as future strategy in biotherapy for esophageal cancer: Study

S1P5 may serve as future strategy in biotherapy for esophageal cancer: Study

NanoString Technologies launches new miRNA assay kits

NanoString Technologies launches new miRNA assay kits

Positive data from NewLink Genetics Phase1/2 study of HyperAcute-Lung cancer immunotherapy

Positive data from NewLink Genetics Phase1/2 study of HyperAcute-Lung cancer immunotherapy

ITI granted AOAC approval for additional Salmonella matrices

ITI granted AOAC approval for additional Salmonella matrices

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

Serametrix announces commercial launch of serum test for measuring serum antibodies

Serametrix announces commercial launch of serum test for measuring serum antibodies

Preclinical results of Avila Therapeutics' AVL-181 and AVL-192 presented at EASL Annual Meeting

Preclinical results of Avila Therapeutics' AVL-181 and AVL-192 presented at EASL Annual Meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.